Tom Hulick, CEO of Strategy Asset Managers, joined Schwab Network’s Morning Trade Live with Sam Vadas to discuss Eli Lilly’s leadership in the weight-loss space and the evolving impact of healthcare innovation on the broader economy.
During the segment, Tom highlighted Lilly’s next-generation weight-loss treatments and discussed how improved health outcomes could contribute to increased productivity, consumer spending, and longer-term economic benefits. The conversation reinforced the importance of innovation-driven growth and SAM’s focus on identifying durable investment opportunities aligned with long-term societal trends.
No rush at all on the media posts—we’re flexible on timing there. And yes, taking another look at the team members afterward sounds great.